Phase III trial of platinum or nonplatinum doublet chemotherapy based on quantitative ERCC1 mRNA expression in advanced-stage non-small-cell lung carcinoma

Aarati Ranganathan, Alex Adjei, Primo Lara

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)170-178
Number of pages9
JournalClinical Lung Cancer
Volume8
Issue number3
StatePublished - Jan 1 2006

Fingerprint

Platinum
Non-Small Cell Lung Carcinoma
Drug Therapy
Messenger RNA

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Phase III trial of platinum or nonplatinum doublet chemotherapy based on quantitative ERCC1 mRNA expression in advanced-stage non-small-cell lung carcinoma. / Ranganathan, Aarati; Adjei, Alex; Lara, Primo.

In: Clinical Lung Cancer, Vol. 8, No. 3, 01.01.2006, p. 170-178.

Research output: Contribution to journalArticle

@article{d1bf891ae9cc4ab99127d0b080165e4d,
title = "Phase III trial of platinum or nonplatinum doublet chemotherapy based on quantitative ERCC1 mRNA expression in advanced-stage non-small-cell lung carcinoma",
author = "Aarati Ranganathan and Alex Adjei and Primo Lara",
year = "2006",
month = "1",
day = "1",
language = "English (US)",
volume = "8",
pages = "170--178",
journal = "Clinical Lung Cancer",
issn = "1525-7304",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Phase III trial of platinum or nonplatinum doublet chemotherapy based on quantitative ERCC1 mRNA expression in advanced-stage non-small-cell lung carcinoma

AU - Ranganathan, Aarati

AU - Adjei, Alex

AU - Lara, Primo

PY - 2006/1/1

Y1 - 2006/1/1

UR - http://www.scopus.com/inward/record.url?scp=33845440321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845440321&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33845440321

VL - 8

SP - 170

EP - 178

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

SN - 1525-7304

IS - 3

ER -